Wednesday, 22 May 2024

New strategies drive growth in Yunnan Baiyao

11 June 2012 | Analysis | By BioSpectrum Bureau

New strategies drive growth in Yunnan Baiyao

The sales revenue of the company increased from $1.49 billion in 2010 to $1.81 billion in 2011

The sales revenue of the company increased from $1.49 billion in 2010 to $1.81 billion in 2011

Ming Hui Wang of Yunnan BaiyoYunnan Baiyao made new strategies for 2011 and the year recorded relocation, expansion of the company's business development space, well-organized production and management, and optimization of internal resources to strengthen the company. The management of the company actively promoted the implementation of major health strategies to maintain a sustained and healthy growth. These strategies helped Yunnan Baiyao to maintain a growth rate of over 21 percent in 2011. The sales revenue of the company increased from $1.49 billion in 2010 to $1.81 billion in 2011.

In the last one year, with its dedicated efforts and focus, Yunnan Baiyao earned multiple accolades in China. It was awarded an honorary title by seventh China Industry Forum for three consecutive years. It was the most authoritative and influential listed companies in the stock market. It also won the 2010-11 self-medication education awards and was named as a valued company.

In 2011, Yunnan Baiyao was acknowledged by Yunnan Provincial Bureau of Quality and Technical Supervision for provincial standard of good conduct pilot enterprises. It was awarded the title of 2010 Taurus top 100 listed companies.

To strengthen the human resources department, Yunnan Baiyo made a structure for rapid and healthy development of human resources management mechanism. It started cultivating the development of reserve talents team with the University of Hong Kong and jointly organized the first phase of reserve talents training camp.

Strengthening its financial management and financial risk control, and to optimize the allocation of funds, the company implemented a comprehensive budget management. It implemented efficient strategies for budget execution and audit efforts to highlight the budget control and cost management. Yunnan Baiyo is constructing a new plant and is actively coordinating internal and external resources to apply for GMP certification.

Yunnan Baiyo is also maintaining a good position in international markets for medicines, health products, medical dressing, daily consumables, and medical makeup and is introducing internationally advanced products, technology and important materials and equipment in the home country.
Being market-and client-oriented, the company carries out reforms and improvement in internal organizing system. The company has six marketing divisions, including medicine division, transdermal product division, health product division, original herbal medicine division, Yunnan Province Pharmaceuticals company, and the overseas business division.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account